Skip to main content

Market Overview

Mid-Day Market Update: Invacare Surges Following Strong Q4 Results; Motif Bio Shares Slide


Midway through trading Thursday, the Dow traded down 0.56 percent to 25,399.80 while the NASDAQ declined 0.15 percent to 7,409.20. The S&P also fell, dropping 0.46 percent to 2,740.28.

Leading and Lagging Sectors

On Thursday, the energy shares climbed 0.4 percent. Meanwhile, top gainers in the sector included Precision Drilling Corporation (NYSE: PDS) up 13 percent, and Marathon Oil Corporation (NYSE: MRO) up 9 percent.

In trading on Thursday, financial shares fell 1.5 percent.

Top Headline

Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected earnings for its second quarter on Wednesday.

Second-quarter earnings came in at 73 cents per share, beating estimates by a penny. Sales came in at $12.4 billion, missing estimates by $10 million.

The company reported strong third-quarter earnings guidance and expects sales growth of 4-6 percent year-over-year. Cisco also added $15 billion to its buyback plan.


Equities Trading UP

Invacare Corporation (NYSE: IVC) shares got a boost, shooting up 71 percent to $9.09 after reporting strong Q4 results.

Shares of Arcimoto, Inc. (NASDAQ: FUV) shot up 59 percent to $5.41. The stock may be moving in sympathy with Electrameccanica, which spiked after a Bloomberg article highlighted its Solo electric vehicle. Arcimoto makes similar electric vehicles.

Precipio, Inc. (NASDAQ: PRPO) shares were also up, gaining 30 percent to $0.2210 after the company reported a 66 percent year-over-year increase in FY18 sales.

Equities Trading DOWN

Motif Bio plc (NASDAQ: MTFB) shares dropped 74 percent to $2.73 after the FDA said it cannot accept the company's new drug application for iclaprim in its current state and indicated additional data may be needed.

Shares of Sierra Wireless, Inc. (NASDAQ: SWIR) were down 25 percent to $11.56 after the company reported downbeat Q4 results and issued weak Q1 guidance.

Caladrius Biosciences, Inc. (NASDAQ: CLBS) was down, falling around 24 percent to $4.06 after the company reported data from its Phase 2a trial of ALBS03 diabetes therapy; data showed no improvement in primary endpoint.


In commodity news, oil traded down 0.3 percent to $53.75 while gold traded down 0.14 percent to $1,313.30.

Silver traded down 0.81 percent Thursday to $15.525, while copper fell 0.11 percent to $2.77.



European shares were mixed today. The eurozone’s STOXX 600 slipped 0.04 percent, the Spanish Ibex Index rose 0.28 percent, while Italy’s FTSE MIB Index declined 0.39 percent. Meanwhile the German DAX declined 0.33 percent, and the French CAC 40 surged 0.18 percent while U.K. shares rose 0.3 percent.


U.S. initial jobless claims increased 4,000 to 239,000 in the latest week. However, economists were expecting a reading of 225,000.

The Producer Price Index dropped 0.1 percent for January, versus economists’ expectations for a 0.1 percent rise.

U.S. retail sales fell 1.2 percent for December, versus economists’ expectations for a 0.1 percent rise.

U.S. business inventories fell 0.1 percent for November.

Domestic supplies of natural gas declined 78 billion cubic feet for the week ended February 8, the U.S. Energy Information Administration reported. Analysts projected a rise of 79 billion cubic feet.

Data on money supply for the recent week will be released at 4:30 p.m. ET.


Related Articles (CSCO + CLBS)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateNews Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at